Preliminary research suggests that using CRISPR to treat cancer is safe in humans and could become a feasible therapeutic method in the future, although its
At first, Stuart Harshbarger thought he’d injured his back lifting furniture and boxes. When the pain started, in 2008, “we’d just moved from Detroit to
Doctors at the University of Pennsylvania posted plans for a clinical trial, which will combat cancer using human immune cells reprogrammed with CRISPR, on ClinicalTrials.gov
The outlook for patients with multiple myeloma has improved dramatically during the past two decades. The median overall survival is now more than 6 years,
Created by ePubSystems. Contact Us for similar site for your university or institute.